Addressing the Challenge of HER2 Heterogeneity in Breast Cancer

Did you know that there is a paradigm shift in the definition of human epidermal growth factor receptor 2 (HER2) status in breast cancer? Credit available for this activity expires: 5/31/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974715?src=mkm_podcast_addon_974715